The Wasatch U.S. Select Fund—Investor Class gained 0.24% but underperformed the benchmark Russell 3000® Growth Index, which ...

Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...

Top 15. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other top dividend contenders. Dividend stocks have remained a popular choice among investors ...